• Home
  • Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma.

Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma.

Author List
Algazi AP, Weber JS, Andrews SC, Urbas P, Munster PN, DeConti RC, Hwang J, Sondak VK, Messina JL, McCalmont T, Daud AI
Publication
British journal of cancer
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1158889
Publication Year
2011
PubMed ID
22127285
Publication Title
Algazi AP, Weber JS, Andrews SC, Urbas P, Munster PN, DeConti RC, Hwang J, Sondak VK, Messina JL, McCalmont T, Daud AI. Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma. Br J Cancer. 2012 Jan 03; 106(1):85-91.